CCantor SSpaceX · SPCX
Cantor Reiterates Overweight on SpaceX, $246 PT
Rating
Buy
Price target
$246
Previous
—
Implied upside
+96%
Cantor Fitzgerald analyst Colin Canfield reiterated an Overweight rating and $246 price target on SpaceX (SPCX) on August 5, 2026.
“We reiterate our PT of $246 based on our balanced approach of 50% EV/EBITDA SOTP ($338), 25% EV/ Sales SOTP ($194) and 25% DCF ($258).
Our 2026E sales and adj. EBITDA estimates are materially unchanged as we assume some pull-forward of 2Q26 Connectivity and AI beat, although we now assume materially greater FCF burn for 2026E.
Our 2027E-2028E sales, adj. EBITDA and FCF estimates rise as we assume greater AI benefits.”
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
